Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma
Kaposi's sarcoma (KS), a multifocal vascular neoplasm linked to human herpesvirus-8 (HHV-8/KS-associated herpesvirus [KSHV]) infection, is the most common AIDS-associated malignancy. Clinical management of KS has proven to be challenging because of its prevalence in immunosuppressed patients an...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Artículo publishedVersion |
Lenguaje: | Inglés |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | http://hdl.handle.net/20.500.12110/paper_00221007_v209_n11_p1985_Croci |
Aporte de: |
id |
paperaa:paper_00221007_v209_n11_p1985_Croci |
---|---|
record_format |
dspace |
spelling |
paperaa:paper_00221007_v209_n11_p1985_Croci2023-06-12T16:43:49Z Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma J. Exp. Med. 2012;209(11):1985-2000 Croci, D.O. Salatino, M. Rubinstein, N. Cerliani, J.P. Cavallin, L.E. Leung, H.J. Ouyang, J. Ilarregui, J.M. Toscano, M.A. Domaica, C.I. Croci, M.C. Shipp, M.A. Mesri, E.A. Albini, A. Rabinovich, G.A. galectin 1 glycan hypoxia inducible factor 1alpha hypoxia inducible factor 2alpha immunoglobulin enhancer binding protein messenger RNA monoclonal antibody reactive oxygen metabolite angiogenesis animal cell animal experiment animal model animal tissue apoptosis article carcinogenesis cell growth cell invasion cell migration cell proliferation controlled study human human cell human tissue hypoxia in vivo study Kaposi sarcoma male mouse nonhuman priority journal protein expression protein function protein protein interaction protein targeting spindle cell tumor regression Animals Anoxia Antibodies, Monoclonal Antibodies, Neutralizing Cell Hypoxia Cell Line, Tumor Cells, Cultured Galectin 1 Gene Expression Regulation, Neoplastic HEK293 Cells Herpesvirus 8, Human Host-Pathogen Interactions Humans Immunoblotting Mice Mice, Inbred C57BL Mice, Knockout Mice, Nude Neovascularization, Pathologic Polysaccharides Protein Binding Reverse Transcriptase Polymerase Chain Reaction RNA Interference Sarcoma, Kaposi Xenograft Model Antitumor Assays Kaposi's sarcoma (KS), a multifocal vascular neoplasm linked to human herpesvirus-8 (HHV-8/KS-associated herpesvirus [KSHV]) infection, is the most common AIDS-associated malignancy. Clinical management of KS has proven to be challenging because of its prevalence in immunosuppressed patients and its unique vascular and inflammatory nature that is sustained by viral and host-derived paracrine-acting factors primarily released under hypoxic conditions. We show that interactions between the regulatory lectin galectin-1 (Gal-1) and specific target N-glycans link tumor hypoxia to neovascularization as part of the pathogenesis of KS. Expression of Gal-1 is found to be a hallmark of human KS but not other vascular pathologies and is directly induced by both KSHV and hypoxia. Interestingly, hypoxia induced Gal-1 through mechanisms that are independent of hypoxia-inducible factor (HIF) 1α and HIF-2α but involved reactive oxygen species-dependent activation of the transcription factor nuclear factor κB. Targeted disruption of Gal-1-N-glycan interactions eliminated hypoxia-driven angiogenesis and suppressed tumorigenesis in vivo. Therapeutic administration of a Gal-1-specific neutralizing mAb attenuated abnormal angiogenesis and promoted tumor regression in mice bearing established KS tumors. Given the active search for HIF-independent mechanisms that serve to couple tumor hypoxia to pathological angiogenesis, our findings provide novel opportunities not only for treating KS patients but also for understanding and managing a variety of solid tumors. © 2012 Croci et al. Fil:Croci, D.O. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Salatino, M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Rubinstein, N. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Ilarregui, J.M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Toscano, M.A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Domaica, C.I. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Mesri, E.A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. 2012 info:eu-repo/semantics/article info:ar-repo/semantics/artículo info:eu-repo/semantics/publishedVersion application/pdf eng info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_00221007_v209_n11_p1985_Croci |
institution |
Universidad de Buenos Aires |
institution_str |
I-28 |
repository_str |
R-134 |
collection |
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) |
language |
Inglés |
orig_language_str_mv |
eng |
topic |
galectin 1 glycan hypoxia inducible factor 1alpha hypoxia inducible factor 2alpha immunoglobulin enhancer binding protein messenger RNA monoclonal antibody reactive oxygen metabolite angiogenesis animal cell animal experiment animal model animal tissue apoptosis article carcinogenesis cell growth cell invasion cell migration cell proliferation controlled study human human cell human tissue hypoxia in vivo study Kaposi sarcoma male mouse nonhuman priority journal protein expression protein function protein protein interaction protein targeting spindle cell tumor regression Animals Anoxia Antibodies, Monoclonal Antibodies, Neutralizing Cell Hypoxia Cell Line, Tumor Cells, Cultured Galectin 1 Gene Expression Regulation, Neoplastic HEK293 Cells Herpesvirus 8, Human Host-Pathogen Interactions Humans Immunoblotting Mice Mice, Inbred C57BL Mice, Knockout Mice, Nude Neovascularization, Pathologic Polysaccharides Protein Binding Reverse Transcriptase Polymerase Chain Reaction RNA Interference Sarcoma, Kaposi Xenograft Model Antitumor Assays |
spellingShingle |
galectin 1 glycan hypoxia inducible factor 1alpha hypoxia inducible factor 2alpha immunoglobulin enhancer binding protein messenger RNA monoclonal antibody reactive oxygen metabolite angiogenesis animal cell animal experiment animal model animal tissue apoptosis article carcinogenesis cell growth cell invasion cell migration cell proliferation controlled study human human cell human tissue hypoxia in vivo study Kaposi sarcoma male mouse nonhuman priority journal protein expression protein function protein protein interaction protein targeting spindle cell tumor regression Animals Anoxia Antibodies, Monoclonal Antibodies, Neutralizing Cell Hypoxia Cell Line, Tumor Cells, Cultured Galectin 1 Gene Expression Regulation, Neoplastic HEK293 Cells Herpesvirus 8, Human Host-Pathogen Interactions Humans Immunoblotting Mice Mice, Inbred C57BL Mice, Knockout Mice, Nude Neovascularization, Pathologic Polysaccharides Protein Binding Reverse Transcriptase Polymerase Chain Reaction RNA Interference Sarcoma, Kaposi Xenograft Model Antitumor Assays Croci, D.O. Salatino, M. Rubinstein, N. Cerliani, J.P. Cavallin, L.E. Leung, H.J. Ouyang, J. Ilarregui, J.M. Toscano, M.A. Domaica, C.I. Croci, M.C. Shipp, M.A. Mesri, E.A. Albini, A. Rabinovich, G.A. Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma |
topic_facet |
galectin 1 glycan hypoxia inducible factor 1alpha hypoxia inducible factor 2alpha immunoglobulin enhancer binding protein messenger RNA monoclonal antibody reactive oxygen metabolite angiogenesis animal cell animal experiment animal model animal tissue apoptosis article carcinogenesis cell growth cell invasion cell migration cell proliferation controlled study human human cell human tissue hypoxia in vivo study Kaposi sarcoma male mouse nonhuman priority journal protein expression protein function protein protein interaction protein targeting spindle cell tumor regression Animals Anoxia Antibodies, Monoclonal Antibodies, Neutralizing Cell Hypoxia Cell Line, Tumor Cells, Cultured Galectin 1 Gene Expression Regulation, Neoplastic HEK293 Cells Herpesvirus 8, Human Host-Pathogen Interactions Humans Immunoblotting Mice Mice, Inbred C57BL Mice, Knockout Mice, Nude Neovascularization, Pathologic Polysaccharides Protein Binding Reverse Transcriptase Polymerase Chain Reaction RNA Interference Sarcoma, Kaposi Xenograft Model Antitumor Assays |
description |
Kaposi's sarcoma (KS), a multifocal vascular neoplasm linked to human herpesvirus-8 (HHV-8/KS-associated herpesvirus [KSHV]) infection, is the most common AIDS-associated malignancy. Clinical management of KS has proven to be challenging because of its prevalence in immunosuppressed patients and its unique vascular and inflammatory nature that is sustained by viral and host-derived paracrine-acting factors primarily released under hypoxic conditions. We show that interactions between the regulatory lectin galectin-1 (Gal-1) and specific target N-glycans link tumor hypoxia to neovascularization as part of the pathogenesis of KS. Expression of Gal-1 is found to be a hallmark of human KS but not other vascular pathologies and is directly induced by both KSHV and hypoxia. Interestingly, hypoxia induced Gal-1 through mechanisms that are independent of hypoxia-inducible factor (HIF) 1α and HIF-2α but involved reactive oxygen species-dependent activation of the transcription factor nuclear factor κB. Targeted disruption of Gal-1-N-glycan interactions eliminated hypoxia-driven angiogenesis and suppressed tumorigenesis in vivo. Therapeutic administration of a Gal-1-specific neutralizing mAb attenuated abnormal angiogenesis and promoted tumor regression in mice bearing established KS tumors. Given the active search for HIF-independent mechanisms that serve to couple tumor hypoxia to pathological angiogenesis, our findings provide novel opportunities not only for treating KS patients but also for understanding and managing a variety of solid tumors. © 2012 Croci et al. |
format |
Artículo Artículo publishedVersion |
author |
Croci, D.O. Salatino, M. Rubinstein, N. Cerliani, J.P. Cavallin, L.E. Leung, H.J. Ouyang, J. Ilarregui, J.M. Toscano, M.A. Domaica, C.I. Croci, M.C. Shipp, M.A. Mesri, E.A. Albini, A. Rabinovich, G.A. |
author_facet |
Croci, D.O. Salatino, M. Rubinstein, N. Cerliani, J.P. Cavallin, L.E. Leung, H.J. Ouyang, J. Ilarregui, J.M. Toscano, M.A. Domaica, C.I. Croci, M.C. Shipp, M.A. Mesri, E.A. Albini, A. Rabinovich, G.A. |
author_sort |
Croci, D.O. |
title |
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma |
title_short |
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma |
title_full |
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma |
title_fullStr |
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma |
title_full_unstemmed |
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma |
title_sort |
disrupting galectin-1 interactions with n-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in kaposi's sarcoma |
publishDate |
2012 |
url |
http://hdl.handle.net/20.500.12110/paper_00221007_v209_n11_p1985_Croci |
work_keys_str_mv |
AT crocido disruptinggalectin1interactionswithnglycanssuppresseshypoxiadrivenangiogenesisandtumorigenesisinkaposissarcoma AT salatinom disruptinggalectin1interactionswithnglycanssuppresseshypoxiadrivenangiogenesisandtumorigenesisinkaposissarcoma AT rubinsteinn disruptinggalectin1interactionswithnglycanssuppresseshypoxiadrivenangiogenesisandtumorigenesisinkaposissarcoma AT cerlianijp disruptinggalectin1interactionswithnglycanssuppresseshypoxiadrivenangiogenesisandtumorigenesisinkaposissarcoma AT cavallinle disruptinggalectin1interactionswithnglycanssuppresseshypoxiadrivenangiogenesisandtumorigenesisinkaposissarcoma AT leunghj disruptinggalectin1interactionswithnglycanssuppresseshypoxiadrivenangiogenesisandtumorigenesisinkaposissarcoma AT ouyangj disruptinggalectin1interactionswithnglycanssuppresseshypoxiadrivenangiogenesisandtumorigenesisinkaposissarcoma AT ilarreguijm disruptinggalectin1interactionswithnglycanssuppresseshypoxiadrivenangiogenesisandtumorigenesisinkaposissarcoma AT toscanoma disruptinggalectin1interactionswithnglycanssuppresseshypoxiadrivenangiogenesisandtumorigenesisinkaposissarcoma AT domaicaci disruptinggalectin1interactionswithnglycanssuppresseshypoxiadrivenangiogenesisandtumorigenesisinkaposissarcoma AT crocimc disruptinggalectin1interactionswithnglycanssuppresseshypoxiadrivenangiogenesisandtumorigenesisinkaposissarcoma AT shippma disruptinggalectin1interactionswithnglycanssuppresseshypoxiadrivenangiogenesisandtumorigenesisinkaposissarcoma AT mesriea disruptinggalectin1interactionswithnglycanssuppresseshypoxiadrivenangiogenesisandtumorigenesisinkaposissarcoma AT albinia disruptinggalectin1interactionswithnglycanssuppresseshypoxiadrivenangiogenesisandtumorigenesisinkaposissarcoma AT rabinovichga disruptinggalectin1interactionswithnglycanssuppresseshypoxiadrivenangiogenesisandtumorigenesisinkaposissarcoma |
_version_ |
1769810378000171008 |